tirzepatide cardiovascular outcomes trial 2024 American Heart Association Scientific Sessions has started off with a bang! Results are in for the SUMMIT study: Treatment with (Mounjaro/ Zepbound) was associated with 38% ⬇️ in combined risk Cardiovascular and Cerebrovascular Outcomes Risk

GLP-1 Medical Weight Loss, Tailored to You Weight Loss Consultations At Soko Skin, Dr

So if you are on your first injection and wondering why the scale has not moved, that is expected

Men on 10 mg lose significantly more than those who stay at 5 mg

The longer the gap in treatment, the bigger the jump in risk up to a 22% increase for heart attack, stroke and death after two years off GLP-1s, largely erasing the cardiovascular benefits gained during treatment

Accessing GLP-1 Therapy Without Breaking Your Budget The total monthly investment for sustainable weight loss through PlexusDx ranges from $129/mo to $349/mo depending on the formulation selected, compared to the $900$1,500 patients typically pay for brand-name GLP-1 injections